Invention Application
- Patent Title: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
-
Application No.: US15674914Application Date: 2017-08-11
-
Publication No.: US20180051012A1Publication Date: 2018-02-22
- Inventor: Markus Boehm , Shawn Cabral , Matthew S. Dowling , Kentaro Futatsugi , Kim Huard , Esther Cheng Yin Lee , Allyn T. Londregan , Jana Polivkova , David A. Price , Qifang Li
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D405/14
- IPC: C07D405/14 ; A61K31/506 ; A61K45/06 ; C07D409/14
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US10071992B2 Diacylglycerol acyl transferase 2 inhibitors Public/Granted day:2018-09-11
Information query
